文献速递浆细胞疾病

多发性骨髓瘤KRAS突变全景的特异性靶向揭示其抗肿瘤活性

Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity.
PubMed 文献 · Blood · 2021-01-01

该研究结合DNA和RNA测序分析756例多发性骨髓瘤患者,发现KRAS是诊断时最常突变的基因,且在疾病复发时持续存在或新出现。使用反义寡核苷酸AZD4785靶向所有KRAS亚型,在体外和体内均显著沉默KRAS并抑制骨髓瘤生长,证实KRAS是驱动基因和治疗靶点。

要点

  • KRAS是多发性骨髓瘤诊断时最常突变的基因。
  • KRAS突变在复发时持续存在或新出现。
  • AZD4785靶向所有KRAS亚型,在体外和体内抑制骨髓瘤生长。

核心结论

  • KRAS是多发性骨髓瘤的驱动基因和治疗靶点,靶向所有KRAS亚型的反义寡核苷酸AZD4785可显著抑制肿瘤生长。

研究设计与样本

  • 结合DNA和RNA测序研究756例多发性骨髓瘤患者。
  • 使用强效选择性反义寡核苷酸AZD4785靶向并下调所有KRAS亚型进行体外和体内功能研究。

主要发现

  • KRAS是诊断时最常突变的基因。
  • KRAS异常在疾病复发时持续存在或新出现。
  • AZD4785显著沉默KRAS,在体外和体内抑制骨髓瘤肿瘤生长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alterations in KRAS have been identified as the most recurring somatic variants in the multiple myeloma (MM) mutational landscape. Combining DNA and RNA sequencing, we studied 756 patients and observed KRAS as the most frequently mutated gene in patients at diagnosis; in addition, we demonstrated the persistence or de novo occurrence of the KRAS aberration at disease relapse. Small-molecule inhibitors targeting KRAS have been developed; however, they are selective for tumors carrying the KRASG12C mutation. Therefore, there is still a need to develop novel therapeutic approaches to target the KRAS mutational events found in other tumor types, including MM. We used AZD4785, a potent and selective antisense oligonucleotide that selectively targets and downregulates all KRAS isoforms, as a tool to dissect the functional sequelae secondary to KRAS silencing in MM within the context of the bone marrow niche and demonstrated its ability to significantly silence KRAS, leading to inhibition of MM tumor growth, both in vitro and in vivo, and confirming KRAS as a driver and therapeutic target in MM.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Sacco A, Federico C, Todoerti K, et al. Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited antitumor activity. Blood. 2021. PMID: 34077955. doi:10.1182/blood.2020010572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。